Home urate monitoring

Suggested

4 studies · 1 recommendation

Last updated: February 2, 2026

Suggested4 studies

Regular home urate self-testing improves target achievement and treatment adherence in gout management

Four studies support home urate monitoring for gout patients. A randomized controlled trial (n=67) found 2-monthly self-monitoring achieved urate targets (≤0.36 mmol/L) in 95% of participants versus 62.9% with annual monitoring (risk difference 0.32, 95% CI 0.13-0.52, p=0.0021). A diagnostic accuracy study (n=30) validated the Easy Touch GCU portable meter against laboratory methods, showing strong correlation (r=0.86) with only 3.9% mean difference. A wearable sweat sensor demonstrated continuous uric acid detection with correlation to serum levels in gout patients. A systematic review of 24 guidelines confirmed consensus on maintaining serum uric acid below 6 mg/dL (360 μmol/L) for long-term control. Frequent self-monitoring enables patients to track progress toward therapeutic targets and supports medication adherence, with lower withdrawal rates observed in the more frequent monitoring group.

Evidence

Evaluation of continued 2-monthly or annual urate monitoring in gout: an extension of the GoutSMART randomised controlled feasibility trial

Authors: Abbas, Hawazin, Alexander, Debbie, Brown, Clare, Hart, Rowan, Krause, Amrey, Riches, Philip L.

Published: November 11, 2024

A randomized controlled trial of 67 gout patients compared 2-monthly urate self-monitoring (n=40) versus annual monitoring (n=27) over 24 months. Participants used a supported self-management approach with urate self-testing and a target of 0.3 mmol/L. At 24 months, 95% (38/40) of 2-monthly monitoring participants achieved urate ≤0.36 mmol/L compared to 62.9% (17/27) of annual monitoring participants. The risk difference was 0.32 (95% CI 0.13 to 0.52; p=0.0021). Withdrawal rates were higher in the annual monitoring group (4 of 5 total withdrawals), suggesting more frequent self-monitoring also improves treatment adherence.

View Source →

Сравнение колориметрического и электрохимического (анализатор Easy Touch GCU) методов определения уровня мочевой кислоты в крови у пациентов с подагрой и гиперурикемией в клинической практике (данные пилотного исследования)

Authors: E. V. Panina, M. S. Eliseev, O. V. Zheliabina, Е. В. Панина, М. С. Елисеев, О. В. Желябина

Published: October 17, 2023

In a diagnostic accuracy study of 30 patients with gout and hyperuricemia meeting ACR/EULAR 2015 criteria, the electrochemical method (Easy Touch GCU Meter) using capillary fingertip blood showed strong agreement with the standard colorimetric laboratory method. The mean difference between methods was only 13.9 μmol/l (3.9% relative to the colorimetric reference). A high correlation coefficient (r = 0.86) demonstrated close linear relationship and good agreement between the two measurement approaches. The method proved applicable for patients who have achieved normouricemia, supporting its utility for ongoing self-monitoring in real clinical practice.

View Source →

A laser-engraved wearable sensor for sensitive detection of uric acid and tyrosine in sweat

Authors: Bo, Xiangjie, Gao, Wei, Hsiai, Tzung K., Kogan, Adam, Li, Zhaoping, Min, Jihong, Pak, On Shun, Song, Yu, Tu, Jiaobing, Wang, Minqiang, Yang, Yiran, Zhang, Haixia, Zhu, Lailai

Published: February 1, 2020

The diagnostic accuracy study evaluated a laser-engraved wearable sensor for simultaneous sweat sampling, chemical sensing, and vital-sign monitoring. Testing in gout patients and healthy controls demonstrated that sweat uric acid levels correlated with serum levels—patients with gout showed higher sweat uric acid than healthy individuals. The device successfully detected low concentrations of uric acid continuously during exercise and following dietary challenges, suggesting potential utility for ongoing gout monitoring outside clinical settings.

View Source →

Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements

Authors: An, Z, Chen, H, Chen, Y, Chung, S-C, Hemingway, H, Kwong, JS-W, Li, L, Li, Q, Li, S, Li, X, Liu, H, Shah, A, Sun, X, Tian, H, Wang, J

Published: August 24, 2019

This systematic review analyzed 24 guidance documents (16 clinical practice guidelines and 8 consensus statements) published between 2003 and 2017, using AGREE II methodology. Recommendations were concordant across guidelines on the target serum uric acid level for long-term control, with most guidelines specifying a target below 6 mg/dL (360 μmol/L). The 2017 British Society of Rheumatology guideline received the highest quality scores. The review scored documents across domains: scope and purpose (median 85.4%, range 66.7%-100.0%) and clarity of presentation (median 79.2%, range 48.6%-98.6%).

View Source →